Elopak ASA carries a market capitalization of 9.48B, placing it among publicly traded companies globally. Its enterprise value stands at 1.48B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 9.48B |
| Enterprise Value | 1.48B |
Elopak ASA currently has 268.84M shares outstanding.
| Shares Outstanding | 268.84M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Elopak ASA trades at a trailing price-to-earnings ratio of 21.34. The price-to-sales ratio is 0.90, and the price-to-book ratio stands at 3.58.
| PE Ratio | 21.34 |
| PS Ratio | 0.90 |
| PB Ratio | 3.58 |
| P/TBV Ratio | 5.93 |
| P/FCF Ratio | 9.63 |
| P/OCF Ratio | 9.63 |
On an enterprise value basis, Elopak ASA trades at an EV/EBITDA multiple of 14.51 and an EV/FCF ratio of 10.42. The EV/Sales ratio of 1.26 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 14.51 provides insight into valuation relative to core operating earnings.
| EV / Sales | 1.26 |
| EV / EBITDA | 14.51 |
| EV / EBIT | 14.51 |
| EV / FCF | 10.42 |
Elopak ASA maintains a current ratio of 1.47, meaning it holds 1.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 131.41, indicating elevated leverage, while an interest coverage ratio of 2.23 demonstrates limited ability to service its debt obligations.
| Current Ratio | 1.47 |
| Quick Ratio | 0.11 |
| Debt / Equity | 131.41 |
| Debt / EBITDA | 4.32 |
| Interest Coverage | 2.23 |
Elopak ASA posts a return on equity of 17.56 and a return on invested capital of 9.56.
| Return on Equity (ROE) | 17.56 |
| Return on Assets (ROA) | 4.88 |
| Return on Invested Capital (ROIC) | 9.56 |
| Return on Capital Employed (ROCE) | 11.65 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 3.73 |
Over the trailing twelve months, Elopak ASA has paid 22.58M in income taxes, reflecting an effective tax rate of 31.23.
| Income Tax | 22.58M |
| Effective Tax Rate | 31.23 |
Elopak ASA's stock has declined approximately -27.09411% over the past 52 weeks. The 50-day moving average sits at 35.46, while the 200-day moving average is 44.40.
| Beta (5Y) | N/A |
| 52-Week Price Change | -27.09411% |
| 50-Day Moving Average | 35.46 |
| 200-Day Moving Average | 44.40 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Elopak ASA generated 1.18B in revenue and converted that into 49.74M in net income, yielding earnings per share of 0.18. EBITDA reached 101.78M, while operating income came in at 101.78M.
| Revenue | 1.18B |
| Gross Profit | 442.07M |
| Operating Income | 101.78M |
| Pretax Income | 72.32M |
| Net Income | 49.74M |
| EBITDA | 101.78M |
| EBIT | 101.78M |
| Earnings Per Share (EPS) | 0.18 |
Elopak ASA holds 34.13M in cash and equivalents against 439.42M in total debt, resulting in a net debt position of 301.73M. Total book value stands at 296.64M, with working capital of 146.60M providing operational flexibility.
| Cash & Cash Equivalents | 34.13M |
| Total Debt | 439.42M |
| Net Debt | 301.73M |
| Equity (Book Value) | 296.64M |
| Book Value Per Share | 1.10 |
| Working Capital | 146.60M |
Elopak ASA produced 110.22M in operating cash flow over the past twelve months.
| Operating Cash Flow | 110.22M |
| Capital Expenditures | N/A |
| Free Cash Flow | 110.22M |
| FCF Per Share | 0.41 |
Elopak ASA operates with a gross margin of 37.59, reflecting its pricing power and cost economics. The operating margin of 8.65 and net profit margin of 4.23 provide insight into operational efficiency.
| Gross Margin | 37.59 |
| Operating Margin | 8.65 |
| Pretax Margin | 6.15 |
| Profit Margin | 4.23 |
| EBITDA Margin | 8.65 |
The company's payout ratio of 42.88 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.08 |
| Dividend Yield | N/A |
| Payout Ratio | 42.88 |
| Shareholder Yield | -1.96 |
| FCF Yield | 10.38 |
Elopak ASA posts an Altman Z-Score of 3.16, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 3.16 |